| 12:10-12:30 | 专题会 |
循证筑基:外源性三重神经酰胺保湿霜辅助治疗儿童AD的临床研究与获益 |
|
||||
| 12:30-12:50 | 专题会 |
知行合一:儿童皮肤屏障护理专家建议与临床规范化实践解读 |
|
||||
| 13:30-13:40 | 致辞 |
开幕致辞 |
|
||||
| 13:40-14:05 | 专题报告 |
新免疫失调性疾病 |
|
||||
| 14:05-14:30 | 专题报告 |
SAVI诊治进展 |
|
||||
| 14:30-14:38 | 大会发言 |
基于Olink技术分析腹型IgA血管炎的炎症生物标志物的诊断价值研究 |
|
||||
| 14:38-14:46 | 大会发言 |
MAIT 细胞通过LIGHT通路异常激活B 细胞在儿童系统性红斑狼疮发病中的作用 |
|
||||
| 14:46-14:54 | 大会发言 |
Clinical efficacy observation of belimumab in the treatment of children with systemic lupus erythematosus and its influence on the autophagy level of peripheral blood mononuclear cells in children |
|
||||
| 14:54-15:02 | 大会发言 |
双等位基因ZNFX1突变致难治性贫血合并间质性肺病1例并文献复习 |
|
||||
| 15:02-15:10 | 大会发言 |
Retrospective analysis of clinical characteristics of subacute necrotizing lymphadenitis in children from a single center in central China |
|
||||
| 15:30-15:55 | 专题报告 |
谈谈关于过敏的几个问题 |
|
||||
| 15:55-16:03 | 大会发言 |
Clinical characteristics, treatment and outcomes of 10 chinese patients with adenosine deaminase 2 deficiency |
|
||||
| 16:03-16:11 | 大会发言 |
以巨噬细胞活化综合征起病的椎体软骨发育不良伴免疫调节异常1例 |
|
||||
| 16:11-16:19 | 大会发言 |
中性粒细胞胞外陷阱在川崎病早期血管内皮细胞损伤中的机制研究 |
|
||||
| 16:19-16:27 | 大会发言 |
RELA移码变异相关儿童炎症性疾病的表型异质性:2例报告 |
|
||||
| 16:27-16:35 | 大会发言 |
ZNF699基因突变所致DEGCAGS综合征的临床及免疫学特征 |
|
||||
| 16:35-16:43 | 大会发言 |
Phenotypic Patterns of Allergic Comorbidity and Associated Health Outcomes in Children: A Population-Based Latent Class Study |
|
||||
| 16:43-16:51 | 大会发言 |
1例XLA合并EV11脑膜脑炎联合抗感染治疗及长期随访 |
|
||||
| 16:51-16:59 | 大会发言 |
Tfh细胞NR4A2/IL-21轴在过敏性哮喘AIT疗效中的作用及机制探究 |
|
||||
| 16:59-17:07 | 大会发言 |
PIKK 家族 ATM/ATR 变异的生物信息学解析:免疫机制关联、冲突变异仲裁与 VUS 优先级评估 |
|
||||
| 17:07-17:15 | 大会发言 |
类克治疗PLCG2突变的APLAID患者的病案1例 |
|
||||
| 17:15-17:30 | 讨论 |
集体答疑、讨论 |
|||||